A patient with metastatic colon cancer received an infusion of CAR T cells targeted to the antigen HER2 (ERBB2) and died 5 days later (55) due to the massive on-target/off-tumor toxicity of the CAR T cells for lung cells that express low levels of HER2. Here, ERBB2 is linked to neoplasm.